Form 8-K - Current report:
SEC Accession No. 0001387131-19-007619
Filing Date
2019-10-15
Accepted
2019-10-15 07:00:41
Documents
19
Period of Report
2019-10-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT txmd-8k_101519.htm   iXBRL 8-K 45697
2 INVESTOR PRESENTATION ex-99_1.htm EX-99.1 11729
6 GRAPHIC txmd001.jpg GRAPHIC 232547
7 GRAPHIC txmd002.jpg GRAPHIC 448234
8 GRAPHIC txmd003.jpg GRAPHIC 172532
9 GRAPHIC txmd004.jpg GRAPHIC 280458
10 GRAPHIC txmd005.jpg GRAPHIC 286110
11 GRAPHIC txmd006.jpg GRAPHIC 190880
  Complete submission text file 0001387131-19-007619.txt   2456333

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT txmd-20191015.xsd EX-101.SCH 3204
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT txmd-20191015_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT txmd-20191015_pre.xml EX-101.PRE 22722
14 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_101519_htm.xml XML 3607
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 191149099
SIC: 2834 Pharmaceutical Preparations